City
Epaper

Vodafone Idea Shares Jump 3% After Telecom Operator Reveals 6-Year Plan to Clear AGR Dues

By Lokmat Times Desk | Updated: January 9, 2026 10:56 IST

Telecom operator Vodafone Idea on Friday laid out a detailed repayment roadmap for its adjusted gross revenue (AGR) liabilities, ...

Open in App

Telecom operator Vodafone Idea on Friday laid out a detailed repayment roadmap for its adjusted gross revenue (AGR) liabilities, under which it will service a portion of the dues at a maximum of Rs 124 crore per year over a six-year period. The company’s shares rose about 3% in early trade after the announcement. The stock is currently trading at Rs. 11.80 against the previous close of Rs. 11.50.

In its stock exchange filing, Vodafone Idea said its AGR liabilities — including principal, interest, penalty and interest on penalty for FY2006-07 to FY2018-19 — outstanding as of December 31, 2025, will be frozen and repaid in a phased manner. As per the Department of Telecommunications (DoT) communication, the company will pay up to Rs 124 crore annually for six years from March 2026 to March 2031. This will be followed by payments of Rs 100 crore per year for four years from March 2032 to March 2035. The balance AGR dues will then be cleared in equal annual instalments over six years from March 2036 to March 2041.Vodafone Idea also said the DoT will constitute a committee to reassess the AGR dues, and the committee’s decision will be final. After the reassessment, the revised AGR amount will be repaid in equal annual instalments between March 2036 and March 2041.

Milan Vaishnav, MSTA, Founder of Gemstone Equity Research & Advisory Services in a moneycontrol report has advised  investors to avoid Vodafone Idea and use any upward moves to exit the stock. “If investors choose to remain invested, exposure should be limited to no more than 5 percent of the total portfolio,” he added.Continuing further he said, it is not  possible to analyze Vodafone Idea purely from a technical perspective. The main drivers of its price over past many quarters is the developments on AGR dues and the rulings from the court that have come from time to time. The stock has rising over the past quarter despite negative divergences on the lead indicators.In my opinion, investors should avoid this stock and use all up moves to exit the stock. If they wish to stay invested, not more than 5 percent of the total portfolio should be allocated to such stocks. Brokerage Emkay Global continued to maintain its 'SELL' rating on Vodafone Idea stock with a target price of ₹6, despite government relief packages, as it believes the company's leverage remains high. The domestic brokerage said that the telco’s financial position remains stressed despite repeated relief packages.

 

 

 

 

 

Tags: Vodafone Idea ShareVodafone Idea LimitedStock marketVodafone IdeaAGR
Open in App

Related Stories

BusinessHDFC Bank Shares Extend Losing Streak Ahead of Q3 Results; Experts Remain Positive On Long-Term Potential

BusinessITC Shares Continue to Fall as Stock Drops 16% in a Month, Extending Investor Losses; Experts Predict 48% Upside In Long-Term

BusinessStock Market Investors Suffer Biggest Single-Day Loss as ₹8 Lakh Crore Wiped Out; , Nifty Slips Below 25,000

BusinessReliance Power Shares Fall Over 50% from Peak, From ₹76.49 to ₹34 : Should You Buy Or Sell the Stock

BusinessVodafone Idea Shares Fall for Second Straight Session; Experts Advise Investors to Exit on Rallies, Limit Portfolio Exposure

Business Realted Stories

BusinessIndia’s energy planning validated in real-world conditions, infra nearly doubles in 10 years: Minister

BusinessLong-term planning driving India's energy readiness, says Hardeep Puri

BusinessVeCura ReSculpt Launches in Kukatpally, Hyderabad; Redefines Non-Surgical Body Sculpting with Science-First Approach

BusinessNutriride: How a Rising Underdog's Trust is Redefining Authentic & Affordable Sports Nutrition in India

BusinessSanvii, India's Fastest-Growing Virtual Influencer, Hits 100K Followers as Xhadow Media Redefines Digital Content